As of Aug 23
| -2.10 / -1.88%|
The 11 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 126.00, with a high estimate of 145.00 and a low estimate of 93.00. The median estimate represents a +15.06% increase from the last price of 109.51.
The current consensus among 14 polled investment analysts is to Hold stock in Eli Lilly and Co. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.